5yxu: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "5yxu" [edit=sysop:move=sysop] |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
==an affinity enhanced T cell receptor in complex with HLA-A0201 restricted HCV NS3 peptide KLVALGINAV== | |||
<StructureSection load='5yxu' size='340' side='right' caption='[[5yxu]], [[Resolution|resolution]] 2.70Å' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[5yxu]] is a 10 chain structure with sequence from [http://en.wikipedia.org/wiki/9hepc 9hepc] and [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5YXU OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5YXU FirstGlance]. <br> | |||
</td></tr><tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">HLA-A, HLAA ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> | |||
[[Category: | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5yxu FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5yxu OCA], [http://pdbe.org/5yxu PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5yxu RCSB], [http://www.ebi.ac.uk/pdbsum/5yxu PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5yxu ProSAT]</span></td></tr> | ||
</table> | |||
== Function == | |||
[[http://www.uniprot.org/uniprot/1A02_HUMAN 1A02_HUMAN]] Involved in the presentation of foreign antigens to the immune system. | |||
__TOC__ | |||
</StructureSection> | |||
[[Category: Human]] | |||
[[Category: Yi, L]] | [[Category: Yi, L]] | ||
[[Category: Affinity enhanced tcr-phla complex]] | |||
[[Category: Immune system]] | |||
Latest revision as of 15:52, 27 February 2019
an affinity enhanced T cell receptor in complex with HLA-A0201 restricted HCV NS3 peptide KLVALGINAV
| ||||||||||||
